Patent Application
20230138911
The present document discloses a urogenital cleansing composition comprising a non-ionic cellulose ether and a triglyceride oil, wherein the urogenital cleansing composition does not contain any additional emulsifier.
The intimate skin of the urogenital area, such as the lower abdomen, is highly fragile and sensitive with its mucous membrane being irritated easily.
Consequently, it may be difficult to clean the urogenital area without affecting the mucous membrane in an adverse way. Accordingly, cleansing compositions intended for the urogenital area have particular requirements in order to function in the delicate, sensitive, and fragile intimate skin area of the lower abdomen.
An object of the present document is to alleviate at least one of the problems discussed above, and to provide advantages and aspects not provided by hitherto known technique.
The present document provides a urogenital cleansing composition comprising:
The present document further provides a method for preparing a urogenital cleansing composition as disclosed herein, the method comprising the steps of:
The present document is also directed to a urogenital cleansing composition as disclosed herein prepared by a method as disclosed herein.
Other features and advantages of the present document will be apparent from the following detailed description, drawings, examples, and from the claims.
The present inventors have surprisingly found that it is possible to produce a homogenous and stable composition comprising a non-ionic cellulose ether and a triglyceride oil without the use of an additional emulsifier and being particularly suited for cleansing of the urogenital area. The urogenital area is a highly sensitive area and cleansing compositions intended for this area have particular requirements compared to cleansing compositions intended for other parts of the body, such as facial cleansing composition.
The present document thus provides a urogenital cleansing composition comprising:
The present urogenital cleansing composition is thus for cleansing of the urogenital area, such as the delicate intimate skin areas in the lower abdomen. The fact that the composition comprises a non-ionic cellulose ether, a triglyceride oil and a pH regulating agent without the use of an additional emulsifier in combination with that the urogenital cleansing composition has a pH within the range of from 3 to 4 with the pH regulating agent being a lactate buffer has been found to provide a surprisingly effective cleansing feeling leaving the consumers a feeling of being rehydrated and not de-hydrated after use. Hence, the urogenital cleansing composition as disclosed herein is a cleanser which gently wash without de-hydrating and without disturbing the pH balance of the delicate intimate skin in the urogenital area. If pH rises in the urogenital area, it can damage cells, cause infection and the skin can become red and dry. Consequently, the urogenital cleansing composition as disclosed herein do not irritate the mucous membrane in the urogenital area.
The urogenital cleansing composition may be denoted an oil-in-water composition.
The non-ionic cellulose ether, aqueous solvent and triglyceride oil are homogenously mixed, and stay homogenously mixed upon storage, despite the lack of an additional emulsifier. By homogenously mixed is in the context of the present document intended that the components are mixed so that one, uniform system is formed.
The at least one non-ionic cellulose ether may be dissolved in the aqueous solvent, thus forming an aqueous non-ionic cellulose ether gel, before being mixed with the triglyceride oil.
When preparing the urogenital cleansing composition of the present document, an aqueous gel comprising a non-ionic cellulose ether and any other ingredients may first be prepared prior to being mixed with the triglyceride oil.
Hence, the at least one non-ionic cellulose ether and the pH-regulating agent, such as the lactate buffer, may be dissolved in the aqueous solvent, thus forming an aqueous non-ionic cellulose ether gel comprising a non-ionic cellulose ether and pH-regulating agent, such as a lactate buffer, before being mixed with the triglyceride oil.
The aqueous non-ionic cellulose ether gel, comprising a non-ionic cellulose ether and a pH-regulating agent may, prior to including the triglyceride oil, have a viscosity of from 35 000 to 100 000 mPas, optionally from 38 000 to 100 000 mPas, optionally from 40 000 to 100 000 mPas, optionally from 45 000 to 100 000 mPas, optionally from 47 000 to 100 000 mPas, optionally from 50 000 to 100 000 mPas, optionally from 52 000 to 100 000 mPas or optionally from 55 000 to 100 000 mPas. By mixing a non-ionic cellulose ether gel having such viscosity with a triglyceride oil in order to achieve a urogenital cleansing composition, it has been found by the present inventors that an improved urogenital cleansing composition may be provided with a stable and pleasant consistency and that is easily applicable. Since the consistency is viscous and not too liquid, the urogenital cleansing composition according to the present document remains in the area during washing, but may at the same time easily be rinsed off, so that no undesired residues of the urogenital cleansing composition remains after cleansing/washing which may otherwise lead to irritation and dehydration of the mucous membrane. Such viscosity of the aqueous non-ionic cellulose ether gel furthermore favours further mixing with the triglyceride oil in order to achieve the urogenital cleansing composition as disclosed herein.
The non-ionic cellulose ether gel may have an osmolality within the range of from 10 to 300 mOsmol/kg, optionally from 10 to 200 mOsmol/kg, such as from 20 to 100 mOsmol/kg, or optionally from 30 to 50 mOsmol/kg. By mixing a non-ionic cellulose ether having such osmolality with a triglyceride oil an improved urogenital cleansing composition preventing the mucosal membrane of the urogenital area to de-hydrate upon use of the urogenital cleansing composition may be provided.
Further, the urogenital cleansing composition as disclosed herein may have a viscosity of from 40 000 to 55 000 mPas. This has been found to provide an enhanced effect of generating a stable and pleasant consistency of the urogenital cleansing composition that is easily applicable and not too liquid. The urogenital cleansing composition thus remains in the area during washing but is at the same time easily rinsed off, so that no undesired residues of the urogenital cleansing composition remains after cleansing/washing. This is of particular importance for the urogenital area, both since it is a sensitive area, but also since complete rinsing may be more difficult in this area comprising skin creases and folds.
The triglyceride oil (or triacylglycerol) may preferably be a vegetable oil. The triglyceride oil may be a long chain triglyceride oil, such as oat oil, olive oil, sunflower oil, or rapeseed oil. The triglyceride oil is typically a medium-chain or long-chain triglyceride oil. Non-limiting examples of long-chain triglyceride oils are soybean oil, olive oil, sunflower oil, rapeseed (e.g. canola) oil and oat oil. Medium-chain triglyceride oils are prepared industrially by esterification of glycerol with octanoic and decanoic acids, obtained from coconut and palm kernel oils. The triglyceride oil may be liquid at room temperature and then denoted a triglyceride oil. This has been found to provide an enhanced effect of generating a urogenital cleansing composition provided with both a cleansing and emollient effect. Traces of the triglyceride oil, which is good for the skin in the urogenital area, remain in the urogenital area after cleansing, thus leaving a pleasant soft feeling after use.
The urogenital cleansing composition may comprise just one triglyceride oil or a mixture of two or more triglyceride oils, such as 2, 3, 4, 5 or 6 different kinds of triglyceride oils. When two or more different triglyceride oils are present in the composition, the ratio between the different triglyceride oils may be the same or different. This has been found to provide a urogenital cleansing composition with a cleansing and emollient effect, leaving a soft feeling after use.
The non-ionic cellulose ether may be selected from the group consisting of methylcellulose (MC), hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), hydroxyethylethylcellulose (HEEC) and hydroxyethylmethylcellulose (H EMC) and any combination thereof. The composition may comprise only one kind of non-ionic cellulose ether or a mixture of two or more different kinds of non-ionic cellulose ethers, such as 2, 3, 4 or 5 different kinds of non-ionic cellulose ethers. At least one of the non-ionic cellulose ether may e.g. be hydroxypropylmethylcellulose (HPMC). This has been found to provide a thickening and stabilizing effect on the non-ionic cellulose ether gel thus facilitating further mixing with a triglyceride oil.
The triglyceride oil may constitute from 1 to 20 wt %, such as 1-18 wt %, optionally 1-15 wt %, 5-20 wt %, or optionally 5-15 wt % based on the total weight of the urogenital cleansing composition. This has been found to provide a urogenital cleansing composition having a cleansing and emollient effect, leaving a soft feeling after use.
The amount of non-ionic cellulose ether in an aqueous non-ionic cellulose ether gel used for preparing a composition according to the present document may be from 1 wt % to 5 wt %, such as 1.5 wt %, 2 wt %, 2.5 wt %, 3 wt %, 3.5 wt %, 4 wt %, or 4.5 wt %. This has been found to provide a thickening and stabilizing effect on the non-ionic cellulose ether gel thus facilitating the further mixing with the triglyceride oil.
The urogenital cleansing composition according to the present document may have a pH within the range of from 3.2 to 4.0, optionally from 3.5 to 4.0, or optionally from 3.7 to 3.9, such as 3.8. The pH of the composition as described is regulated by the presence of a pH-regulating agent in the composition, the pH regulating agent being a lactate buffer. The concentration of a pH-regulating agent in a non-ionic cellulose gel used in preparing the composition of the present document may be from 20 to 100 mM, or optionally from 20 to 75 mM, optionally from 20 to 50 mM, optionally from 20 to 40 mM, or optionally from 20 to 30 mM, such as 25 mM, in an aqueous solution. This has been found to provide a urogenital cleansing composition which is particularly adapted for the urogenital area which prevents dehydration of the mucosal membrane upon use.
The urogenital cleansing composition as described herein may further comprise a preservative, such as benzoic acid. This provides an enhanced shelf life of the urogenital cleansing composition.
An aqueous non-ionic cellulose ether gel used for preparing the urogenital cleanings composition of the present document may comprise from 3 wt % to 4 wt %, such as 3 wt % to 3.5 wt %, such as 3.2 wt % hydroxypropylmethylcellulose (HPMC), a lactate buffer in a concentration of from 20 to 40 mM and optionally a preservative, such as benzoic acid, at a concentration of from 0.05 to 0.15 mg/g, the composition having a pH within the range of from 3.5 to 4, such as 3.8. This has been found to provide a urogenital cleansing composition which is particularly adapted for the urogenital area, preventing dehydration of the mucosal membrane upon use.
The urogenital cleansing composition as disclosed herein may consist of at least one non-ionic cellulose ether, a pH-regulating agent, an aqueous solvent, at least one triglyceride oil, and optionally a preservative. This has been found to provide a urogenital cleansing composition which is particularly adapted for the urogenital area, preventing dehydration of the mucosal membrane upon use.
In total, the urogenital cleansing composition may consist of from 1 to 20 wt % triglyceride oil, from 0.8 to 4.0 wt % non-ionic cellulose ether, such as 2.56 wt % hydroxypropylmethylcellulose (HPMC), from 16 to 32 mM of lactate buffer solution, a preservative, such as benzoic acid, from 0.04 to 0.12 wt %, and an aqueous solvent which constitutes the remaining part of the urogenital composition such that the total amount is 100 wt %, the composition having a pH within the range of from 3.5 to 4, such as 3.8. This has been found to provide a urogenital cleansing composition which is particularly adapted for the urogenital area preventing dehydration of the mucosal membrane upon use.
The urogenital cleansing composition as disclosed herein is free from alcohol. The composition of the present document may be administered to the urogenital area one or more times a day, such as 1-5 times a day such as, 1, 2, 3, 4, or 5 times a day.
There is also provided a method for preparing the urogenital cleansing composition described herein, the method comprising the steps of:
When an aqueous non-ionic cellulose ether gel as disclosed herein is mixed with the triglyceride oil, the aqueous gel may, prior to mixing, optionally have a viscosity of from 38 000 to 100 000 mPas, optionally from 40 000 to 100 000 mPas, optionally from 45 000 to 100 000 mPas, optionally from 47 000 to 100 000 mPas, optionally from 50 000 to 100 000 mPas, optionally from 52 000 to 100 000 mPas or optionally from 55 000 to 100 000 mPas.
Further, the present document is also directed to a urogenital cleansing composition as disclosed herein prepared by a method as disclosed herein.
The composition disclosed herein may be denoted a urogenital cleansing composition. The invention will be further described in the following examples, which do not limit the scope of the invention described in the claims
Experimental Section
To a 100 ml glass beaker were added VagiVital (Peptonic Medical AB, containing 3.2 wt % hypromellose Benecel K15M (hydroxypropylmethylcellulose (HPMC)), 25 mM lactate buffer and 0.1% benzoic acid in purified water) and a triglyceride oil in the amounts specified in Tables 1 and 2. The mixture was homogenised for 3 minutes at 10,000 rpm (revolutions per minute) using a rotor/stator homogeniser, such as a DI 25 basic dispersion tool (high-speed dispersion and emulsifying unit from Ika-Werke, Germany). The resulting composition was then stored at room temperature and its stability in terms of homogeneity was observed.
Two compositions comprising VagiVital, a medium-chain triglyceride oil and a mild emulsifier were prepared using the method of Example 1 but with the amounts of ingredients according to Table 1. The emulsifier was added after the addition of the triglyceride oil. The batch size was 56 g.
As can be seen in Table 1, the compositions were homogenous directly after preparation but separated upon storage at room temperature.
Five compositions comprising VagiVital (according to Example 1) and a triglyceride oil without an emulsifier were prepared using the method of Example 1 but with the amounts of ingredients according to Table 2. The batch size was 56 g.
Avena Sativa (Oat) Kernel Oil)
As can be seen in Table 2, the compositions comprising hydroxypropylmethylcellulose (HPMC), lactate buffer and benzoic acid in purified water (VagiVital, Peptonic Medical AB) and a triglyceride oil are shown to be stable even though they do not comprise an emulsifier.
Twenty women took part in a study. The women tested a urogenital cleansing composition for cleansing the urogenital area according to the present disclosure daily during 17 days.
The women were thereafter asked to evaluate if they experienced that the urogenital cleansing composition did indeed clean, and if the use of the urogenital cleansing composition gave the impression of feeling hydrated, i.e. not de-hydrated.
The urogenital cleansing composition used in the survey consisted of 75-95 wt % aqueous solvent, 5-10 wt % triglyceride oil, 1-5 wt % non-ionic cellulose ether, 0.2-2 wt % lactate buffer and 0.1-1 wt % benzoic acid and had a pH of 3.7-3.9.
The results are shown in Table 3:
As can be seen in Table 3, 95% of the women who participated in the survey experienced both that the urogenital cleansing composition indeed cleaned and left a hydrated feeling. It can thus be concluded that the urogenital cleansing composition cleanses without dehydrating the urogenital area.
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
Unless expressly described to the contrary, each of the preferred features described herein can be used in combination with any and all of the other herein described preferred features.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2050564-0 | May 2020 | SE | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2021/062622 | 5/12/2021 | WO |
